Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events
Michela Brambatti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeff S. Healey(Population Health Research Institute), Michael R. Gold(Medical University of South Carolina), Georges H. Mairesse(Cliniques du Sud Luxembourg), Carmine Muto(Goethe University Frankfurt), Alessandro Capucci(Marche Polytechnic University), Marta Halytska(Goethe University Frankfurt), Wei Q. Deng(Goethe University Frankfurt), Carsten W. Israel(Evangelisches Krankenhaus Bielefeld), Juliet Nakamya(Population Health Research Institute), Stuart J. Connolly(Population Health Research Institute), Carlos A. Morillo(Spanish National Centre for Cardiovascular Research), Eric Fain(St. Jude Medical Center), Mark D. Carlson(Kent Hospital), Chu‐Pak Lau(Queen Mary Hospital), Isabelle C. Van Gelder(Goethe University Frankfurt), Stefan H. Hohnloser(Goethe University Frankfurt)
Cited by 669
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k